Reflections on the “New Biotechnology and Pharmaceutical Industry Commitment to Patients and the Public”
We read with great interest the Opinion piece in Stat News in which more than 200 corporate leaders—mostly from small and mid-sized companies, as well as some investors—signed on to what…